Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Praxis Precision Medicines Inc PRAX

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two... see more

Bullboard (NDAQ:PRAX)

View:
Post by whytestockson Nov 26, 2024 2:15pm

Praxis Precision Medicines to Showcase Updates from Largest

BREAKING NEWS: $PRAX Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual MeetingBOSTON, Nov. 26 ...more  
Post by whytestockson Aug 13, 2024 7:30pm

Praxis Precision Medicines Provides Corporate Update and Rep

NEWS: $PRAX Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsUp to four programs in registrational phase by 2025 Planned interim analysis for ...more  
Post by MikeTesteron Aug 01, 2024 5:38pm

Praxis Precision Medicines, Inc. (NASDAQ:PRAX): A Promising

https://beyondspx.com/2024/08/01/praxis-precision-medicines-inc-nasdaqprax-a-promising-biopharmaceutical-company-translating-genetic-insights-into-therapies-for-cns-disorders/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities